Bellberry New Investigator Award
Tracks
Track 1
| Wednesday, December 10, 2025 |
| 4:00 PM - 6:00 PM |
| Hall E1 |
|
Sponsored By:
Bellberry Limited
|
Speaker
Dr Jonathan Brett
Clinical Pharmacologist
UNSW Sydney & St Vincent's Hospital
Psilocybin-assisted psychotherapy: A trans-diagnostic therapy?
4:00 PM - 4:30 PMBiography
Dr Jonathan Brett is a senior staff specialist in clinical toxicology and addiction medicine at St. Vincent’s Hospital, Sydney, clinical director of the Psychiatry and Non-Prescription Drug and Alcohol Unit and a clinical toxicologist with the NSW Poison’s Information Centre. He has fellowships with the Royal Australian College of Physicians in clinical pharmacology, toxicology and addiction medicine. He is a conjoint Professor with St. Vincent’s Clinical School, UNSW and a Senior NHMRC Research Fellow with the Medicines Policy Unit of Centre for Big Data Research in Health, UNSW. He is president elect of the Royal Australian College of Physicians Chapter of Addiction Medicine. He completed his PhD in biostatistics in 2018 with a focus on the use of big data measure the quality use of psychotropics in mental health and has a research interest in psychopharmacology.
Dr Quynh Dinh
Research Fellow
RMIT University
Characterising a rat model of polycystic kidney disease to identify therapeutic targets
4:30 PM - 5:00 PMBiography
Dr Quynh Dinh is a lecturer in Pharmaceutical Sciences at RMIT University. Dr Dinh's research focuses on understanding inflammatory pathways that contribute to the development of cognitive impairment in cardiovascular disease and dementia.
Dr Abhipree Sharma
Postdoctoral Fellow
Monash University
Understanding sex-based cardiometabolic responses to contemporary diabetes therapies
5:00 PM - 5:30 PMBiography
Dr. Abhipree Sharma received her PhD in 2024 at Monash University in the Heart Failure Pharmacology laboratory. Since completing her PhD, she has continued as a postdoctoral fellow in the same laboratory. Her research focuses on investigating the potential sex-specific cardiac and systemic effects of newer classes of glucose-lowering therapies in patients with type 2 diabetes and in animal models of obesity and diabetes.
Dr Julia Chitty
Research Fellow
Monash University
Novel in vivo and ex vivo applications utilising transgenic TGFβ overexpressing mice
5:30 PM - 6:00 PMBiography
Julia is a dedicated pharmacologist specialising in lung diseases, focusing on COPD and viral AECOPD, with a special interest in the cytokine Transforming Growth Factor Beta. Julia is currently a Research Fellow at Monash University, where her research aims to develop a novel mouse model of COPD to assess therapeutic strategies for viral-induced inflammation and lung damage. I utilise cutting-edge ex vivo models, including precision-cut lung slices (PCLS), to test drug efficacy and improve treatments for COPD.
Chair
Andrew Rowland
Professor
Flinders University
Mouna Sawan
Senior Lecturer
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney